 | This article may rely excessively on sources too closely associated with the subject , potentially preventing the article from being verifiable and neutral.(July 2023) |
Daphne Simeon is an American psychiatrist, best known for her research on depersonalization disorder.
Simeon is a graduate of Columbia University's medical school, psychiatry residency and fellowship program, and psychoanalytic institute. Simeon works at Beth Israel Medical Center in New York, at the Family Center for Bipolar Disorder.[ citation needed ]
Simeon was an associate professor of psychiatry at the Mount Sinai School of Medicine in New York City, where she did research, supervised, and taught. It is here that she ran a clinic that specifically treated depersonalization disorder. She also co-chaired an international task force that generated new recommendations for the DSM-V classification of dissociative disorders.[ citation needed ]
With editor and magazine writer Jeffrey Abugel, Simeon co-authored the book Feeling Unreal: Depersonalization Disorder and the Loss of the Self ( ISBN 0-19-517022-9), published by Oxford University Press in 2006. The book provides a thorough exploration of depersonalization disorder and represents more than a century of research. It presents a distillation of the scientific research on this disorder, the philosophical and literary references, as well as current treatment options. [1]
Kay Redfield Jamison is an American clinical psychologist and writer. Her work has centered on bipolar disorder, which she has had since her early adulthood. She holds the post of the Dalio Professor in Mood Disorders and Psychiatry at Johns Hopkins University School of Medicine and is an Honorary Professor of English at the University of St Andrews.
Depersonalization can consist of a detachment within the self, regarding one's mind or body, or being a detached observer of oneself. Subjects feel they have changed and that the world has become vague, dreamlike, less real, lacking in significance or being outside reality while looking in. It can be described as feeling like one is on “autopilot” and that the person's sense of individuality or selfhood has been hindered or suppressed.
Dissociation is a concept that has been developed over time and which concerns a wide array of experiences, ranging from a mild emotional detachment from the immediate surroundings, to a more severe disconnection from physical and emotional experiences. The major characteristic of all dissociative phenomena involves a detachment from reality, rather than a loss of reality as in psychosis.
Depersonalization-derealization disorder is a mental disorder in which the person has persistent or recurrent feelings of depersonalization and/or derealization. Depersonalization is described as feeling disconnected or detached from one's self. Individuals may report feeling as if they are an outside observer of their own thoughts or body, and often report feeling a loss of control over their thoughts or actions. Derealization is described as detachment from one's surroundings. Individuals experiencing derealization may report perceiving the world around them as foggy, dreamlike/surreal, or visually distorted.
Dissociative disorders (DD) are conditions that involve disruptions or breakdowns of memory, awareness, identity, or perception. People with dissociative disorders use dissociation as a defense mechanism, pathologically and involuntarily. The individual experiences these dissociations to protect themselves. Some dissociative disorders are triggered by psychological trauma, but depersonalization-derealization disorder may be preceded only by stress, psychoactive substances, or no identifiable trigger at all.
Lisa Dixon is a Professor of Psychiatry at the Columbia University Irving Medical Center and the Director of the Division of Behavioral Health Services and Policy Research within the Department of Psychiatry. Her research focuses on improving the quality of care for individuals diagnosed with serious mental illnesses. She directs the Center for Practice Innovations (CPI) at the New York State Psychiatric Institute, where she oversees the implementation of evidence-based practices for individuals with serious mental illnesses for the New York State Office of Mental Health. She leads OnTrackNY, a statewide treatment program for adolescents and young adults experiencing their first episode of psychosis.
The Icahn School of Medicine at Mount Sinai, formerly the Mount Sinai School of Medicine, is a private medical school in New York City, New York, United States. The school is the academic teaching arm of the Mount Sinai Health System, which manages eight hospital campuses in the New York metropolitan area, including Mount Sinai Hospital and the New York Eye and Ear Infirmary.
The Massachusetts General Hospital Psychiatry Academy is an educational organization for psychiatrists, psychologists, other mental health professionals, and other healthcare professionals who diagnose and treat patients with mental health disorders. It is directly organized and managed by the Department of Psychiatry at Massachusetts General Hospital, which is owned by Mass General Brigham, the largest healthcare provider in Massachusetts.
Frederick King Goodwin was an American psychiatrist and Clinical Professor of Psychiatry at the George Washington University Medical Center, where he was also director of the Center on Neuroscience, Medical Progress, and Society. He was a specialist in bipolar disorder and recurrent depression.
Dennis S. Charney is an American biological psychiatrist and researcher, with expertise in the neurobiology and treatment of mood and anxiety disorders. He is the author of Neurobiology of Mental Illness, The Physician's Guide to Depression and Bipolar Disorders and Molecular Biology for the Clinician, as well as the author of over 600 original papers and chapters. In 2022, he was listed #52 on Research.com's "Top Medicine Scientists in the United States," with an h-index of 194 with 146,109 citations across 651 publications. Charney is known for demonstrating that ketamine is effective for treating depression. Ketamine's use as a rapidly-acting anti-depressant is recognized as a breakthrough treatment in mental illness.
Derealization is an alteration in the perception of the external world, causing those with the condition to perceive it as unreal, distant, distorted or falsified. Other symptoms include feeling as if one's environment is lacking in spontaneity, emotional coloring, and depth. It is a dissociative symptom that may appear in moments of severe stress.
Sophia Frangou is a professor of psychiatry at the Icahn School of Medicine at Mount Sinai where she heads the Psychosis Research Program. She is a Fellow of the Royal College of Psychiatrists and vice-chair of the RCPsych Panamerican Division. She is a Fellow of the European Psychiatric Association (EPA) and of the American Psychiatric Association (APA). She served as vice-president for Research of the International Society for Bipolar Disorders from 2010 to 2014. She has also served on the Council of the British Association for Psychopharmacology. She is founding member of the EPA NeuroImaging section and founding chair of the Brain Imaging Network of the European College of Neuropsychopharmacology. She is one of the two Editors of European Psychiatry, the official Journal of the European Psychiatric Association.
Suzanne Segal (1955–1997) was an American writer and teacher about spiritual enlightenment, known for her sudden experience of self-realization which she wrote about in her book Collision With the Infinite: A Life Beyond the Personal Self.
Maria Iandolo New is a professor of Pediatrics, Genomics and Genetics at Icahn School of Medicine at Mount Sinai in New York City. She is an expert in congenital adrenal hyperplasia (CAH), a genetic condition affecting the adrenal gland that can affect sexual development.
Igor Galynker is an American psychiatrist, clinician and researcher. His diverse interests include bipolar disorder, suicide prevention, and the role of family in psychiatric illness. He has published on these topics both in professional journals and in the lay press. Most recently his research has been devoted to describing a suicide-specific clinical state, a phenotype of the Suicide Crisis Syndrome (SCS).
Rachel Yehuda is a professor of psychiatry and neuroscience, the vice chair for veterans affairs in the psychiatry department, and the director of the traumatic stress studies division at the Mount Sinai School of Medicine. She also leads the PTSD clinical research program at the neurochemistry and neuroendocrinology laboratory at the James J. Peters VA Medical Center. In 2020 she became director of the Center for Psychedelic Psychotherapy and Trauma Research at Mount Sinai.
Gregor Hasler, M.D. is a Swiss psychiatry researcher, psychiatrist and psychotherapist. He is professor and chair of psychiatry and psychotherapy at the University of Fribourg in Switzerland. His research areas covers stress, depression, bipolar disorders, and eating disorders.
Susan Lynn McElroy is Chief Research Officer at Lindner Center of HOPE.
Trisha Suppes is a professor at Stanford University in the School of Medicine, Department of Psychiatry and Behavioral Sciences. She also works at the VA Palo Alto Health Care System as director of the Bipolar and Depression Research Program. She is noted for being an expert in the treatment and management of bipolar disorder. She been the author or co-author of over 200 peer-reviewed articles and has written numerous academic textbooks for the treatment of Bipolar Disorder. Suppes' recent work includes exploring the biological basis of mood disorders.
Dolores Malaspina M.D., M.S., MSPH is an American psychiatrist and director of the psychiatry program at the Icahn School of Medicine at Mount Sinai and the Anita Steckler and Joseph Steckler Professor of Psychiatry at New York University School of Medicine and the director of InSPIRES, the Institute for Social and Psychiatric Initiatives.
| International | |
|---|---|
| National | |
